Lactobreath: A Pilot Study to Diagnose Lactose Intolerance Based on the Exhaled Breath Metabolome

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Food intolerances affect many people and can cause discomfort and dietary challenges. One common cause is difficulty digesting certain carbohydrates called FODMAPs. Diagnosing food intolerance is often done by excluding and then slowly reintroducing these carbohydrates or using a hydrogen breath test, but these methods have limitations. To address these issues, this project uses the breath we exhale to find markers for lactose intolerance as a model for food intolerance diagnosis. Our aim is to identify breath markers for lactose tolerance and intolerance and link them to metabolic traits, including those found in urine. We use a real-time breath analysis method and a special sensor to measure gases in the digestive system, and we also explore genetic factors using saliva samples. This project aims to help clinicians better identify patients who should follow low FODMAP diets and provide non-invasive breath tests to predict how patients will respond to these diets. It will also advance the use of breath analysis for personalized nutrition, contributes to the broader field of food intolerance research, and has the potential to benefit millions of individuals worldwide.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Men and women

• Swiss and non-Swiss living in the Zurich area (if necessary, beyond Zürich in Switzerland),

• Ability/desire to provide informed consent and partake in the procedures of the study

• Aged 18-65 years at screening

• Agreement to refrain from all other treatments and products used for dairy intolerance (e.g., Lactaid® dietary supplements) during study involvement

• Willing to return for all study visits and complete all study-related procedures, including fasting before and during the intervention

• Able to understand and provide written informed consent in English and/or German.

Locations
Other Locations
Switzerland
ETH Zurich
RECRUITING
Zurich
Contact Information
Primary
Stamatios Giannoukos, PhD
stamatios.giannoukos@org.chem.ethz.ch
+41 44 632 61 12
Backup
Kathryn J. Pimentel, PhD
Kathryn.pimentel@agroscope.admin.ch
+41(0)58 467 3187
Time Frame
Start Date: 2024-06-24
Estimated Completion Date: 2025-12
Participants
Target number of participants: 120
Treatments
Experimental: Lactose solution
Single ingestion of a lactose solution (25 g lactose dissolved in 150 mL water).
Placebo_comparator: Glucose solution
Single ingestion of a glucose solution (13 g glucose dissolved in 150 mL water).
Related Therapeutic Areas
Sponsors
Collaborators: Swiss Allergy Centre, Agroscope Liebefeld-Posieux Research Station ALP, University of Zurich
Leads: ETH Zurich

This content was sourced from clinicaltrials.gov